Hospital
Jane Phillips Memorial Medical Center, INC.
Jane Phillips Memorial Medical Center, INC. was paid $6.79M by Medicaid between Jan 2018 and Nov 2024, across 66 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoJANE PHILLIPS MEMORIAL MEDICAL CENTER, INC.
BARTLESVILLE, OK 74006
BARTLESVILLE, OK 74006
33aNPI1215914254assigned 12/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.79M
24GClaims79,106
24DCodes billed66
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#21 of 75
Median peer was paid$3.66M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,534 | $1.15M | |
| 2019 | 11,015 | $872K | |
| 2020 | 5,778 | $537K | |
| 2021 | 8,633 | $806K | |
| 2022 | 12,419 | $1.16M | |
| 2023 | 16,923 | $1.57M | |
| 2024incomplete | 7,804 | $709K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 13,629 | 13,473 | $2.10M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 3,986 | 3,906 | $1.28M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 5,721 | 5,642 | $1.27M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11% | 6,671 | 6,532 | $778K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 3,636 | 3,616 | $351K |
| 80053 | Comprehensive metabolic panel | 2.3% | 8,889 | 8,642 | $154K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.2% | 832 | 343 | $146K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.1% | 496 | 493 | $142K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.6% | 191 | 190 | $106K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 2,810 | 2,679 | $69K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 10,531 | 10,237 | $69K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 133 | 93 | $63K |
54 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,210 | $44K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 547 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 725 | $34K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 12 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,131 | $18K |
| 43248 | <1% | 38 | $14K | |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 12 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 910 | $9K |
| 83735 | <1% | 1,266 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 153 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,102 | $6K |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 14 | $6K |
| 84100 | <1% | 1,164 | $5K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 24 | $4K |
| 81001 | <1% | 1,423 | $4K | |
| 81025 | <1% | 531 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 272 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 68 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,043 | $3K |
| 87807 | <1% | 224 | $3K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 27 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 67 | $2K |
| 81003 | <1% | 731 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 17 | $1K |
| 84484 | <1% | 128 | $1K | |
| 87081 | <1% | 204 | $1K | |
| 83605 | <1% | 122 | $1K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 15 | $894.06 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 814 | $694.27 |
| 83690 | <1% | 109 | $605.80 | |
| 82550 | <1% | 102 | $573.84 | |
| 80305 | <1% | 52 | $554.43 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,056 | $366.48 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $142.60 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 842 | $131.11 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $85.89 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 17 | $32.87 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 440 | $27.66 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 245 | $10.02 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 27 | $9.59 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,944 | $7.39 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 13 | $6.96 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 146 | $5.06 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 415 | $4.47 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 13 | $2.24 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 40 | $0.60 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $0.59 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 13 | $0.45 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 13 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 12 | $0.00 |
| J3490 | Unclassified drugs | 0% | 12 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOORE, MICHAEL (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Kismet Sux LLC | Sergeant Bluff, IA | $827K |
| Kismet RDK, LLC | Red Oak, IA | $419K |
| Centervilleabington CS | Centerville, IN | $173K |
| Oceana Dental Center PLLC | Oceana, WV | $52K |
| Lantis Enterprises, INC | Billings, MT | $44K |
| Michael D Moore Od PS INC | Olympia, WA | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.